These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 30359014)
1. Preclinical Evaluation of the First Adenosine A Guo M; Gao ZG; Tyler R; Stodden T; Li Y; Ramsey J; Zhao WJ; Wang GJ; Wiers CE; Fowler JS; Rice KC; Jacobson KA; Kim SW; Volkow ND J Med Chem; 2018 Nov; 61(22):9966-9975. PubMed ID: 30359014 [TBL] [Abstract][Full Text] [Related]
2. Discovery of Highly Potent Adenosine A Guo M; Bakhoda A; Gao ZG; Ramsey JM; Li Y; O'Conor KA; Kelleher AC; Eisenberg SM; Kang Y; Yan X; Javdan C; Fowler JS; Rice KC; Hooker JM; Jacobson KA; Kim SW; Volkow ND ACS Chem Neurosci; 2021 Sep; 12(18):3410-3417. PubMed ID: 34469110 [TBL] [Abstract][Full Text] [Related]
3. Design and pharmacological profile of a novel covalent partial agonist for the adenosine A Yang X; Dilweg MA; Osemwengie D; Burggraaff L; van der Es D; Heitman LH; IJzerman AP Biochem Pharmacol; 2020 Oct; 180():114144. PubMed ID: 32653590 [TBL] [Abstract][Full Text] [Related]
4. The antidepressant-like effect of guanosine involves the modulation of adenosine A Camargo A; Bettio LEB; Rosa PB; Rosa JM; Altê GA; Rodrigues ALS Purinergic Signal; 2023 Jun; 19(2):387-399. PubMed ID: 36166131 [TBL] [Abstract][Full Text] [Related]
5. Use of 11C-MPDX and PET to study adenosine A1 receptor occupancy by nonradioactive agonists and antagonists. Paul S; Khanapur S; Sijbesma JW; Ishiwata K; Elsinga PH; Meerlo P; Dierckx RA; van Waarde A J Nucl Med; 2014 Feb; 55(2):315-20. PubMed ID: 24434292 [TBL] [Abstract][Full Text] [Related]
6. 8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for in vivo imaging of the A Humpert S; Schneider D; Bier D; Schulze A; Neumaier F; Neumaier B; Holschbach M Eur J Med Chem; 2024 May; 271():116380. PubMed ID: 38615410 [TBL] [Abstract][Full Text] [Related]
7. Modulating effect of adenosine deaminase on function of adenosine A1 receptors. Sun WC; Cao Y; Jin L; Wang LZ; Meng F; Zhu XZ Acta Pharmacol Sin; 2005 Feb; 26(2):160-5. PubMed ID: 15663892 [TBL] [Abstract][Full Text] [Related]
9. Increased Binding Potential of Brain Adenosine A Hayashi S; Inaji M; Nariai T; Oda K; Sakata M; Toyohara J; Ishii K; Ishiwata K; Maehara T J Neurotrauma; 2018 Jan; 35(1):25-31. PubMed ID: 28728462 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of bivalent ligands against A(1)-D(1) receptor heteromers. Shen J; Zhang L; Song WL; Meng T; Wang X; Chen L; Feng LY; Xu YC; Shen JK Acta Pharmacol Sin; 2013 Mar; 34(3):441-52. PubMed ID: 23334237 [TBL] [Abstract][Full Text] [Related]
11. A Positive Allosteric Modulator of the Adenosine A1 Receptor Selectively Inhibits Primary Afferent Synaptic Transmission in a Neuropathic Pain Model. Imlach WL; Bhola RF; May LT; Christopoulos A; Christie MJ Mol Pharmacol; 2015 Sep; 88(3):460-8. PubMed ID: 26104547 [TBL] [Abstract][Full Text] [Related]
12. Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A Zuccarini M; Lambertucci C; Carluccio M; Giuliani P; Ronci M; Spinaci A; Volpini R; Ciccarelli R; Di Iorio P Cells; 2021 Dec; 10(12):. PubMed ID: 34944069 [TBL] [Abstract][Full Text] [Related]
13. Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A Schneider D; Oskamp A; Holschbach M; Neumaier B; Bier D; Bauer A Nucl Med Biol; 2020; 82-83():1-8. PubMed ID: 31838339 [TBL] [Abstract][Full Text] [Related]
14. Lack of efficacy of a partial adenosine A1 receptor agonist in neuropathic pain models in mice. Metzner K; Gross T; Balzulat A; Wack G; Lu R; Schmidtko A Purinergic Signal; 2021 Sep; 17(3):503-514. PubMed ID: 34313915 [TBL] [Abstract][Full Text] [Related]
15. The ADORA1 mutation linked to early-onset Parkinson's disease alters adenosine A Sarasola LI; Del Torrent CL; Pérez-Arévalo A; Argerich J; Casajuana-Martín N; Chevigné A; Fernández-Dueñas V; Ferré S; Pardo L; Ciruela F Biomed Pharmacother; 2022 Dec; 156():113896. PubMed ID: 36279718 [TBL] [Abstract][Full Text] [Related]
16. Functional Impact of the G279S Substitution in the Adenosine A Nasrollahi-Shirazi S; Szöllösi D; Yang Q; Muratspahic E; El-Kasaby A; Sucic S; Stockner T; Nanoff C; Freissmuth M Mol Pharmacol; 2020 Sep; 98(3):250-266. PubMed ID: 32817461 [TBL] [Abstract][Full Text] [Related]